Access Pharmaceuticals Announces New Data on Angiolix(R)

...nney, Department of Biochemistry, demonstrate that angiolix has unusually high accumulation in multiple solid tumor types, including breast and ovarian cancer. angiolix interferes with binding of a proprietary marker kn... breast cancer tumors. "This new data shows that angiolix interferes with binding of lactadherin on new bloo...

Angiolix in Medical Technology

Access and Somanta Announce Data to be Presented on Angiolix at ASCO Oncology Conference

Pre-clinical Data Suggests Angiolix Can Inhibit Breast Cancer Growth By 75% DALLAS and IRVINE, Calif., June 04, 2007 /PRNewswire-FirstCall/ -- Access Pharmaceuticals, Inc. (Bulletin Board: ACCP) and Somanta Pharmaceuticals, Inc. (Bulletin Board: SMPM) announced today that a scientific abstract out...

Access Pharmaceuticals Presents new Combination Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody

... New data demonstrates that angiolix has similar efficacy to Avastin alone and in combi...n with chemotherapy. The efficacies determined for angiolix combinations were comparable to those of Avastin combinations. The mechanism of action of angiolix is considerably more tumor specific than that of A...

Access Pharmaceuticals Presents New Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody

...esented data this week from preclinical studies on angiolix showing that by blocking lactadherin, angiolix has both an anti-angiogenic effect as well as a di...ncer effect in vivo; this effect was enhanced when angiolix was given in combination with conventional chemoth...

Angiolix in Biological Technology

Access Pharmaceuticals Presents New Data at International Symposium Showing Company's Angiolix(R) Monoclonal Antibody has Potential to Treat Cancer by Attacking Cancer Stem Cells

...fic Officer -- Europe, presented data showing that angiolix has the potential to prevent the growth of cancer ...n. In the presentation, Dr. Epenetos showed that angiolix has been shown not only to block new blood vessels...erial College London, UK to assess the efficacy of angiolix in a wide range of tumor models. These studies aim...